Breast cancer conference calls for support for elderly patients and for independent academic researchMarch 20, 2004Safeguarding academic research, improving individual risk assessment, greater attention to elderly cancer breast cancer patients, and a rethink on care after breast cancer were the four areas highlighted by participants at the 4th European Breast Cancer Conference (EBCC-4) in Hamburg today (20 March 2004). Delegates used an electronic voting system to select these issues for special attention in the next two years. Clinicians, scientists and patients agreed the Hamburg Statement at the end of a five-day conference at which they heard about the latest developments in breast cancer, the most frequent cause of cancer death among European women. Participants underlined the importance of independent academic research and called for the allocation of money from the EU central budget - for example the Tobacco Fund - to translational research, and for the encouragement of private donations to breast cancer research by increasing tax deductibility levels in Member States. Increasingly, women wish to know about their individual risk of getting breast cancer and the conference called for risk-reducing interventions to be made available to patients without cost. For women with a serious family history of breast cancer, delegates wished full genetic counselling and testing to be made available to the patient free of charge. The needs of elderly breast cancer patients are often neglected, despite the demographic changes which mean that this is a growing problem. The conference called for there to be no upper age limit in the design of standard treatment plans, and for patient participation in clinical trials to be decided according to performance status and not by age. Finally, delegates said that after-care for breast cancer patients should not be limited to detecting relapse but should include psychological support and the management of treatment side effects. Care after breast cancer should be planned by a multidisciplinary clinic after discussion with the patient. MR Communication and Analysis Ltd |
|||||||||||||||||||||
| Related Breast Cancer Current Events and Breast Cancer News Articles Researchers Identify Role of Gene in Tumor Development, Growth and Progression Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine researchers have identified a gene that may play a pivotal role in two processes that are essential for tumor development, growth and progression to metastasis. UCLA researchers create 'fly paper' to capture circulating cancer cells Just as fly paper captures insects, an innovative new device with nano-sized features developed by researchers at UCLA is able to grab cancer cells in the blood that have broken off from a tumor. Fertility procedures need not delay breast cancer treatment for younger women A new study published in the November issue of the Journal of the American College of Surgeons shows that breast cancer patients under 40 years old who undergo fertility preservation do not face a significant delay in the treatment of their disease when their care is coordinated in a timely fashion. Coffee break: Compound brewing new research in colon, breast cancer A compound in coffee has been found to be estrogenic in studies by Texas AgriLife Research scientists. Drugs to treat anemia in cancer patients linked to thromboembolism Medications frequently given to cancer patients to reduce their risk of anemia are associated with an increased risk of deep vein thrombosis or pulmonary embolism, according to new research led by Dawn Hershman, M.D, M.S., co-director of the breast cancer program at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital/Columbia University Medical Center. Discovery in worms by Queen's researchers points to more targeted cancer treatment Researchers at Queen's University have found a link between two genes involved in cancer formation in humans, by examining the genes in worms. The groundbreaking discovery provides a foundation for how tumor-forming genes interact, and may offer a drug target for cancer treatment. FDA approved leukemia drugs shows promise in ovarian cancer cells The drug Sprycel, approved for use by the U.S. Food and Drug Administration in patients with chronic myeloid leukemia, significantly inhibited the growth and invasiveness of ovarian cancer cells and also promoted their death, a study by researchers with UCLA's Jonsson Comprehensive Cancer Center found. Carnegie Mellon researchers link health-care debate to risk of dying in US and Europe The current health care debate in the United States is complicated. Trade-offs between heath care expenditures, lifestyle choices and life expectancy have been suggested but seldom clearly demonstrated. Scientists uncover new key to the puzzle of hormone therapy and breast cancer The use of postmenopausal hormone therapy has decreased over time in the United States, which researchers suggest may play a key role in the declining rate of atypical ductal hyperplasia, a known risk factor for breast cancer. Breast density associated with increased risk of cancer recurrence A new study finds that women treated for breast cancer are at higher risk of cancer recurrence if they have dense breasts. Published in the December 15, 2009 issue of Cancer, a peer-reviewed journal of the American Cancer Society, the study's results indicate that breast cancer patients with dense breasts may benefit from additional therapies following surgery, such as radiation. More Breast Cancer Current Events and Breast Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||